Global Research Antibodies & Reagents Market Research 2024-2029 Featuring Prominent Players - Bio-Rad Laboratories, Bio-Techne, Danaher, F.Hoffmann La-Roche, Merck, and Thermo Fisher Scientific
April 10, 2024 07:04 ET
|
Research and Markets
Dublin, April 10, 2024 (GLOBE NEWSWIRE) -- The "Global Research Antibodies & Reagents Market - Outlook & Forecast 2024-2029" report has been added to ResearchAndMarkets.com's offering.The...
Global Anticancer Drug Market Estimated to Reach USD 172.52 Billion in 2023 with Continued Growth Projected Through 2029
April 03, 2024 11:51 ET
|
Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Anticancer Drug Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
North America Leads the Way in Recombinant Cell Culture Supplements Market with Projected Robust Growth through 2028
April 02, 2024 12:54 ET
|
Research and Markets
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "North America Recombinant Cell Culture Supplements Market, Competition, Forecast & Opportunities, 2018-2028" report has been added to ...
Bio-Manufacturing Market Expected to Reach USD 29.67 Billion by 2028
March 27, 2024 15:32 ET
|
Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "Bio-Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
Global Research Antibodies Market Projected to Reach $5.5 Billion by 2030, Driven by Advances in Personalized Medicine
March 25, 2024 13:05 ET
|
Research and Markets
Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Research Antibodies Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. ...
Global CLL Therapeutics Market Set to Reach $9.2 Billion by 2032
March 25, 2024 11:14 ET
|
Research and Markets
Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Chronic Lymphocytic Leukemia (CLL) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032" report has been...
Innovation Waves in Immuno-oncology Therapy Development - Next-gen Cell Therapies and Precision Immunotherapies are Driving Growth and New Product Development
March 21, 2024 05:13 ET
|
Research and Markets
Dublin, March 21, 2024 (GLOBE NEWSWIRE) -- The "Innovation Waves in Immuno-oncology Therapy Development" report has been added to ResearchAndMarkets.com's offering. Immuno-oncology (I-O)...
Monoclonal Antibodies in Veterinary Health: Global and Regional Market Analysis by Animal Type, Application, End User, and Country - Forecast to 2033
March 18, 2024 05:49 ET
|
Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibodies in Veterinary Health Market: Focus on Animal Type, Application, and End User, Regional Analysis, and Competitive...
PD-1 and PD-L1 Inhibitors Competitive Landscape Report 2024: Clinical Assessment of Over 200 Drugs Being Developed by More than 180 Companies
March 01, 2024 08:58 ET
|
Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2024" report has been added to ResearchAndMarkets.com's offering.This "PD-1 and PD-L1 Inhibitors -...
Global Therapeutic Antibody Market Research, 2019-2023 and 2024-2029
February 27, 2024 10:04 ET
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Global Therapeutic Antibody Market (2023 Edition): Analysis By Antibody Type (Monoclonal, Bispecific, Drug Conjugates, Others), Source (Fully human,...